FDA applicant

Blackrock Neuromed

Salt Lake City, UT2 decisions2013–20160 recalls

FDA records 2 decisions for Blackrock Neuromed (Salt Lake City, UT) from 2013 to 2016: 2 510(k) clearances. Most are in product codes GYC (Electrode, Cortical) and GWQ (Full-Montage Standard Electroencephalograph). Its devices cite 7 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Blackrock Neuromed, LLC”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Blackrock Neuromed’s devices, and how often a recall has named them.

FDA decisions per year

1in 2016

2013high 1 (2013) · low 0 (2014)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2013.

FIG. 1 — Blackrock Neuromed by year, 2013–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Blackrock Neuromed’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Blackrock”

FDA records each applicant name separately; these may or may not be the same firm.

Blackrock Microsystems 3

Blackrock Neuromed

Which product codes does it file in?

Whose devices does it build on?

Who builds on its devices?

Which of its devices are cited most?

What has FDA decided for it lately?

Other applicant names beginning “Blackrock”